Published in J Gen Intern Med on February 24, 2009
Nicotinic acetylcholine receptors and depression: a review of the preclinical and clinical literature. Psychopharmacology (Berl) (2010) 1.31
Utilization of services in a randomized trial testing phone- and web-based interventions for smoking cessation. Nicotine Tob Res (2011) 1.31
Behavioral counseling and varenicline treatment for smoking cessation. Am J Prev Med (2010) 1.27
Adherence to varenicline in the COMPASS smoking cessation intervention trial. Nicotine Tob Res (2011) 1.18
Two decades of smoking cessation treatment research on smokers with depression: 1990-2010. Nicotine Tob Res (2012) 1.12
Past major depression and smoking cessation outcome: a systematic review and meta-analysis update. Addiction (2013) 1.12
Treating tobacco dependence in a medical setting. CA Cancer J Clin (2009) 1.08
Neuronal nicotinic acetylcholine receptors as pharmacotherapeutic targets for the treatment of alcohol use disorders. CNS Neurol Disord Drug Targets (2010) 1.06
Electrophysiological perspectives on the therapeutic use of nicotinic acetylcholine receptor partial agonists. J Pharmacol Exp Ther (2011) 1.03
Varenicline for Smoking Cessation in Schizophrenia: Safety and Effectiveness in a 12-Week, Open-Label Trial. J Dual Diagn (2012) 0.97
The nicotinic acetylcholine receptor as a target for antidepressant drug development. ScientificWorldJournal (2012) 0.90
Smoking outcome by psychiatric history after behavioral and varenicline treatment. J Subst Abuse Treat (2010) 0.89
Exploring the "active ingredients" of an online smoking intervention: a randomized factorial trial. Nicotine Tob Res (2014) 0.87
Varenicline for smoking cessation: nausea severity and variation in nicotinic receptor genes. Pharmacogenomics J (2011) 0.87
A Review of Varenicline's Efficacy and Tolerability in Smoking Cessation Studies in Subjects with Schizophrenia. J Addict Res Ther (2011) 0.86
Differential modulation of brain nicotinic acetylcholine receptor function by cytisine, varenicline, and two novel bispidine compounds: emergent properties of a hybrid molecule. J Pharmacol Exp Ther (2013) 0.85
Varenicline efficacy and safety among methadone maintained smokers: a randomized placebo-controlled trial. Addiction (2014) 0.85
Low incidence of adverse events following varenicline initiation among opioid dependent smokers with comorbid psychiatric illness. Drug Alcohol Depend (2013) 0.82
Varenicline for tobacco dependence: panacea or plight? Expert Opin Pharmacother (2011) 0.81
Primary care of the renal transplant patient. J Gen Intern Med (2010) 0.80
Accuracy of a brief screening scale for lifetime major depression in cigarette smokers. Psychol Addict Behav (2011) 0.79
Depressive symptoms among patients receiving varenicline and bupropion for smoking cessation. J Subst Abuse Treat (2014) 0.77
Smoking cessation after brain damage does not lead to increased depression: implications for understanding the psychiatric complications of varenicline. Cogn Behav Neurol (2012) 0.76
Rationale and design of a randomized controlled trial of varenicline directly observed therapy delivered in methadone clinics. Addict Sci Clin Pract (2014) 0.76
Smoking cessation: an economic analysis and review of varenicline. Clinicoecon Outcomes Res (2009) 0.75
Clinical utility of varenicline for smokers with medical and psychiatric comorbidity. Int J Chron Obstruct Pulmon Dis (2009) 0.75
Measures and predictors of varenicline adherence in the treatment of nicotine dependence. Addict Behav (2017) 0.75
Transitioning from adequate to inadequate sleep duration associated with higher smoking rate and greater nicotine dependence in a population sample. Addict Behav (2017) 0.75
The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire. Br J Addict (1991) 63.91
The Hopkins Symptom Checklist (HSCL): a self-report symptom inventory. Behav Sci (1974) 11.10
Signs and symptoms of tobacco withdrawal. Arch Gen Psychiatry (1986) 10.11
Effects of abstinence from tobacco: valid symptoms and time course. Nicotine Tob Res (2007) 5.57
Effect of maintenance therapy with varenicline on smoking cessation: a randomized controlled trial. JAMA (2006) 5.19
Smoking cessation and the course of major depression: a follow-up study. Lancet (2001) 4.23
Smoking cessation with varenicline, a selective alpha4beta2 nicotinic receptor partial agonist: results from a 7-week, randomized, placebo- and bupropion-controlled trial with 1-year follow-up. Arch Intern Med (2006) 3.30
Efficacy and safety of the novel selective nicotinic acetylcholine receptor partial agonist, varenicline, for smoking cessation. Arch Intern Med (2006) 3.30
Perceived stress, quitting smoking, and smoking relapse. Health Psychol (1990) 3.26
Nicotine dependence, major depression, and anxiety in young adults. Arch Gen Psychiatry (1991) 2.92
A double-blind study evaluating the long-term safety of varenicline for smoking cessation. Curr Med Res Opin (2007) 2.75
Symptoms of tobacco withdrawal. A replication and extension. Arch Gen Psychiatry (1991) 2.51
Nicotine receptor partial agonists for smoking cessation. Cochrane Database Syst Rev (2008) 2.46
Varenicline in the routine treatment of tobacco dependence: a pre-post comparison with nicotine replacement therapy and an evaluation in those with mental illness. Addiction (2007) 2.38
Varenicline improves mood and cognition during smoking abstinence. Biol Psychiatry (2008) 2.29
Exacerbation of schizophrenia by varenicline. Am J Psychiatry (2007) 2.27
Heavy smokers, smoking cessation, and clonidine. Results of a double-blind, randomized trial. JAMA (1988) 2.12
Varenicline-induced manic episode in a patient with bipolar disorder. Am J Psychiatry (2007) 2.06
Cognitive-behavioral intervention increases abstinence rates for depressive-history smokers. J Consult Clin Psychol (1994) 2.03
Nicotine withdrawal versus other drug withdrawal syndromes: similarities and dissimilarities. Addiction (1994) 1.80
Nicotine withdrawal symptoms and psychiatric disorders: findings from an epidemiologic study of young adults. Am J Psychiatry (1992) 1.74
Telephone counseling as an adjunct to antidepressant treatment in the primary care system. A pilot study. Eff Clin Pract (2000) 1.55
Patterns of change in depressive symptoms during smoking cessation: who's at risk for relapse? J Consult Clin Psychol (2002) 1.54
Cigarette smoking and major depression. J Addict Dis (1998) 1.34
Smoking cessation, clonidine, and vulnerability to nicotine among dependent smokers. Clin Pharmacol Ther (1993) 1.31
Bupropion SR and counseling for smoking cessation in actual practice: predictors of outcome. Nicotine Tob Res (2003) 1.29
FDA warns of adverse events linked to smoking cessation drug and antiepileptics. JAMA (2008) 1.08
Varenicline treatment for smokers with schizophrenia: a case series. J Clin Psychiatry (2008) 1.06
Varenicline-induced mixed mood and psychotic episode in a patient with a past history of depression. CNS Spectr (2008) 1.01
Impact of symptoms experienced by varenicline users on tobacco treatment in a real world setting. J Subst Abuse Treat (2008) 1.01
Predictors of 12-month outcome in smokers who received bupropion sustained-release for smoking cessation. CNS Drugs (2008) 0.99
Neuropsychiatric disturbance after initiation of varenicline in a patient with a history of alcohol abuse and major depression. Am J Health Syst Pharm (2008) 0.91
PharmGKB update: I. Genetic variants of the organic cation transporter 2 (OCT2, SLC22A2). Pharmacol Rev (2003) 0.89
Cholinergic nicotinic receptor genes implicated in a nicotine dependence association study targeting 348 candidate genes with 3713 SNPs. Hum Mol Genet (2006) 13.16
Measures of abstinence in clinical trials: issues and recommendations. Nicotine Tob Res (2003) 11.72
Novel genes identified in a high-density genome wide association study for nicotine dependence. Hum Mol Genet (2006) 7.90
Effectiveness of home blood pressure monitoring, Web communication, and pharmacist care on hypertension control: a randomized controlled trial. JAMA (2008) 6.04
A meta-analysis of estimated genetic and environmental effects on smoking behavior in male and female adult twins. Addiction (2003) 4.37
Use of electronic cigarettes among state tobacco cessation quitline callers. Nicotine Tob Res (2013) 3.41
Genetic and environmental determinants of human NK cell diversity revealed by mass cytometry. Sci Transl Med (2013) 3.41
Multiple distinct risk loci for nicotine dependence identified by dense coverage of the complete family of nicotinic receptor subunit (CHRN) genes. Am J Med Genet B Neuropsychiatr Genet (2009) 2.86
Aversive and reinforcing opioid effects: a pharmacogenomic twin study. Anesthesiology (2012) 2.85
Female sex and oral contraceptive use accelerate nicotine metabolism. Clin Pharmacol Ther (2006) 2.71
Theory-guided, empirically supported avenues for intervention on HIV medication nonadherence: findings from the Healthy Living Project. AIDS Patient Care STDS (2003) 2.67
Pain sensitivity and opioid analgesia: a pharmacogenomic twin study. Pain (2012) 2.44
Prospective assessment after pediatric cardiac ablation: demographics, medical profiles, and initial outcomes. J Cardiovasc Electrophysiol (2004) 2.44
The effectiveness and cost effectiveness of telephone counselling and the nicotine patch in a state tobacco quitline. Tob Control (2007) 2.38
HIV transmission risk behavior among men and women living with HIV in 4 cities in the United States. J Acquir Immune Defic Syndr (2004) 2.37
Evaluation of the PHQ-2 as a brief screen for detecting major depression among adolescents. Pediatrics (2010) 2.27
CYP2A6 genotype and the metabolism and disposition kinetics of nicotine. Clin Pharmacol Ther (2006) 2.21
Mitochondrial DNA content: its genetic heritability and association with renal cell carcinoma. J Natl Cancer Inst (2008) 2.17
Nicotinic acetylcholine receptor beta2 subunit gene implicated in a systems-based candidate gene study of smoking cessation. Hum Mol Genet (2008) 2.12
CD38 expression in chronic lymphocytic leukemia is regulated by the tumor microenvironment. Blood (2008) 2.00
Evaluation of the Patient Health Questionnaire-9 Item for detecting major depression among adolescents. Pediatrics (2010) 1.89
Ask-Advise-Connect: a new approach to smoking treatment delivery in health care settings. JAMA Intern Med (2013) 1.86
Systematic biological prioritization after a genome-wide association study: an application to nicotine dependence. Bioinformatics (2008) 1.85
Effectiveness of bupropion sustained release for smoking cessation in a health care setting: a randomized trial. Arch Intern Med (2003) 1.73
Reliability of adult retrospective recall of lifetime tobacco use. Nicotine Tob Res (2008) 1.70
The Healthy Living Project: an individually tailored, multidimensional intervention for HIV-infected persons. AIDS Educ Prev (2005) 1.53
Non-replication of genetic association studies: is DAT all, folks? Nicotine Tob Res (2002) 1.50
Genetic research and smoking behavior. JAMA (2007) 1.42
Cost-effectiveness of different combinations of bupropion SR dose and behavioral treatment for smoking cessation: a societal perspective. Am J Manag Care (2004) 1.33
Electronic communications and home blood pressure monitoring (e-BP) study: design, delivery, and evaluation framework. Contemp Clin Trials (2007) 1.31
Utilization of services in a randomized trial testing phone- and web-based interventions for smoking cessation. Nicotine Tob Res (2011) 1.31
Bupropion SR and counseling for smoking cessation in actual practice: predictors of outcome. Nicotine Tob Res (2003) 1.29
Validity of retrospective assessments of nicotine dependence: a preliminary report. Addict Behav (2005) 1.28
Depressive symptoms and metabolic risk in adult male twins enrolled in the National Heart, Lung, and Blood Institute twin study. Psychosom Med (2003) 1.28
Heritability of plasma sex hormones and hormone binding globulin in adult male twins. J Clin Endocrinol Metab (2005) 1.28
Test-retest reliability of web-based retrospective self-report of tobacco exposure and risk. J Med Internet Res (2009) 1.27
Behavioral counseling and varenicline treatment for smoking cessation. Am J Prev Med (2010) 1.27
Quantitative genetic modeling of regional brain volumes and cognitive performance in older male twins. Biol Psychol (2002) 1.27
Perceived adverse effects of antiretroviral therapy. J Pain Symptom Manage (2005) 1.24
Nicotinic acetylcholine receptor variation and response to smoking cessation therapies. Pharmacogenet Genomics (2013) 1.24
Challenges in addressing depression in HIV research: assessment, cultural context, and methods. AIDS Behav (2011) 1.22
Heritability of cigarette smoking and alcohol use in Chinese male twins: the Qingdao twin registry. Int J Epidemiol (2006) 1.21
Genetics of nicotine dependence and pharmacotherapy. Biochem Pharmacol (2007) 1.21
Health behavior change: can genomics improve behavioral adherence? Am J Public Health (2012) 1.20
Adherence to varenicline in the COMPASS smoking cessation intervention trial. Nicotine Tob Res (2011) 1.18
Prevalence and characteristics of smokers at 30 Pacific Northwest colleges and universities. Nicotine Tob Res (2007) 1.18
Resequencing of nicotinic acetylcholine receptor genes and association of common and rare variants with the Fagerström test for nicotine dependence. Neuropsychopharmacology (2010) 1.17
Smoking cessation in a blue-collar population: results from an evidence-based pilot program. Am J Ind Med (2002) 1.16
Mutagen sensitivity has high heritability: evidence from a twin study. Cancer Res (2006) 1.16
The impact of a free nicotine patch starter kit on quit rates in a state quit line. Nicotine Tob Res (2008) 1.15
Depressive symptoms in adolescence: the association with multiple health risk behaviors. Gen Hosp Psychiatry (2010) 1.15
Medication adherence and sexual risk behavior among HIV-infected adults: implications for transmission of resistant virus. AIDS Behav (2007) 1.14
The ability of plasma cotinine to predict nicotine and carcinogen exposure is altered by differences in CYP2A6: the influence of genetics, race, and sex. Cancer Epidemiol Biomarkers Prev (2013) 1.13
Ethnic differences in predictors of adolescent smoking onset and escalation: a longitudinal study from 7th to 12th grade. Nicotine Tob Res (2006) 1.13
Nicotine patches and uninsured quitline callers. A randomized trial of two versus eight weeks. Am J Prev Med (2008) 1.13
A multidimensional model for characterizing tobacco dependence. Nicotine Tob Res (2003) 1.12
Clinical trial participant characteristics and saliva and DNA metrics. BMC Med Res Methodol (2009) 1.11
Physical and economic consequences of climate change in Europe. Proc Natl Acad Sci U S A (2011) 1.09
Increased genetic vulnerability to smoking at CHRNA5 in early-onset smokers. Arch Gen Psychiatry (2012) 1.08
The relationship between socioeconomic status, ethnicity, and cigarette smoking in urban adolescents. Prev Med (2002) 1.06
The impact of smoking cessation on objective and subjective markers of sleep: review, synthesis, and recommendations. Nicotine Tob Res (2004) 1.06
Measuring addiction propensity and severity: the need for a new instrument. Drug Alcohol Depend (2010) 1.05
Mutagen sensitivity and genetic variants in nucleotide excision repair pathway: genotype-phenotype correlation. Cancer Epidemiol Biomarkers Prev (2007) 1.05
Dopamine genes and nicotine dependence in treatment-seeking and community smokers. Neuropsychopharmacology (2009) 1.04
The Twin Research Registry at SRI International. Twin Res Hum Genet (2012) 1.04
Adolescent smoking trajectories and nicotine dependence. Nicotine Tob Res (2008) 1.03
Validity of recall of tobacco use in two prospective cohorts. Am J Epidemiol (2010) 1.03
Intergenerational transmission of tobacco use and dependence: a transdisciplinary perspective. Nicotine Tob Res (2003) 1.01
Impact of symptoms experienced by varenicline users on tobacco treatment in a real world setting. J Subst Abuse Treat (2008) 1.01
Asthma discordance in twins is linked to epigenetic modifications of T cells. PLoS One (2012) 1.01
Association of tobacco dependence and quit attempt duration with Rasch-modeled withdrawal sensitivity using retrospective measures. Addiction (2009) 1.01
The Ask-Advise-Connect approach for smokers in a safety net healthcare system: a group-randomized trial. Am J Prev Med (2013) 1.00
Prospective assessment after pediatric cardiac ablation: recurrence at 1 year after initially successful ablation of supraventricular tachycardia. Heart Rhythm (2004) 0.99
Tailoring nicotine replacement therapy: rationale and potential approaches. CNS Drugs (2006) 0.99
Gene-gene interactions between CYP2B6 and CYP2A6 in nicotine metabolism. Pharmacogenet Genomics (2007) 0.97
Children of persons with Alzheimer disease: what does the future hold? Alzheimer Dis Assoc Disord (2008) 0.97
A prospective evaluation of the relationships between smoking dosage and body mass index in an adolescent, biracial cohort. Addict Behav (2003) 0.97
Changes in Mini-Mental State Exam in community-dwelling older persons over 6 years: relationship to health and neuropsychological measures. Neuroepidemiology (2003) 0.97
A study of depressive symptoms and smoking behavior in adult male twins from the NHLBI twin study. Nicotine Tob Res (2003) 0.97
Determination of optimized multidisciplinary care team for maximal antiretroviral therapy adherence. J Acquir Immune Defic Syndr (2012) 0.96
Insurance coverage, usual source of care, and receipt of clinically indicated care for comorbid conditions among adults living with human immunodeficiency virus. Med Care (2005) 0.96
A placebo controlled randomized trial of the effects of phenylpropanolamine and nicotine gum on cessation rates and postcessation weight gain in women. Addict Behav (2005) 0.95
Adolescents with suicidal ideation: health care use and functioning. Acad Pediatr (2011) 0.95
Adolescent reports of physician counseling for smoking. Pediatrics (2002) 0.95